Examkin

All practice questions

1687 questions

All types8,270Multiple choice4,249Multiple select325Numeric160Matching1,849Ordering1,687
Question 561Question →

An obstetrician is evaluating a multiparous patient at term who is in active labor with intact membranes. The fetal station is -2. To accelerate labor progress, an artificial rupture of membranes is performed. Immediately following the procedure, the fetal heart rate monitor shows a sudden, sustained bradycardia of 70/min. Pelvic examination reveals a soft, pulsating, rope-like structure protruding through the cervical os ahead of the fetal vertex. Arrange the following interventions in the most appropriate chronological order for managing this acute obstetric emergency, from the most immediate bedside action to final definitive care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing umbilical cord prolapse is to immediately elevate the presenting part manually, reposition the patient to utilize gravity, administer tocolytics to stop contractions, transport the patient to the OR with continuous manual elevation, and ultimately perform an emergent cesarean delivery.
Umbilical cord prolapse is a catastrophic obstetric emergency requiring a highly choreographed, sequential response to prevent fetal asphyxia. The absolute most critical first step is the immediate physical relief of cord compression; this is achieved by the provider inserting a hand into the vagina to manually elevate the fetal presenting part off the cord. Concurrently, the patient is repositioned into a knee-chest or steep Trendelenburg position to allow gravity to shift the fetus away from the pelvis. While emergency surgery is being arranged, a rapid-acting tocolytic (e.g., terbutaline) is often administered to stop uterine contractions, which would otherwise exacerbate cord compression. The patient is then transported to the operating suite with the provider maintaining continuous manual elevation of the fetal head. Finally, an emergent cesarean delivery is performed as the definitive, life-saving intervention.

Step-by-Step Solution

1
Diagnose the obstetric emergency.
The presence of a pulsating mass in the vagina immediately following amniotomy indicates an umbilical cord prolapse.
This is a life-threatening emergency causing rapid fetal asphyxia due to mechanical compression of the umbilical vessels.
2
Relieve the mechanical cord compression immediately.
Manual elevation of the presenting part and repositioning the mother into a steep Trendelenburg or knee-chest position.
Lifting the fetal head off the cord restores umbilical blood flow; gravity assists in keeping the fetus out of the pelvis.
3
Optimize fetal status while preparing for emergency surgery.
Administration of an intravenous tocolytic agent (e.g., terbutaline).
Halting uterine contractions reduces further intermittent compression of the cord between the fetal head and the maternal pelvis.
4
Transport the patient safely to the operating suite.
Moving to the OR while maintaining the provider's hand in the vagina.
Elevation of the fetal head must be continuous until the neonate is delivered; removing the hand will cause immediate recurrent compression.
5
Perform definitive surgical management.
Emergent cesarean delivery.
Vaginal delivery is contraindicated in cord prolapse (unless delivery is completely imminent), necessitating an emergent laparotomy for safe extraction.

Key Concept

Management of umbilical cord prolapse prioritizes the immediate relief of cord compression through manual elevation and maternal repositioning, followed by rapid medical stabilization (tocolytics) and execution of an emergent cesarean delivery.
Estimated Time:1m 30s
Question 562Question →

A 26-year-old woman is evaluated in the urgent care setting after seeking postcoital contraception. She reports a single episode of unprotected vaginal intercourse approximately 90 hours prior to arrival. Her medical history is notable for a high body mass index (BMI) of 33 kg/m². During the review of systems, she mentions recent onset of lower abdominal discomfort. Pelvic examination reveals a friable cervix with mucopurulent discharge, marked cervical motion tenderness, and bilateral adnexal tenderness. A point-of-care urine pregnancy test is negative.

Arrange the following emergency contraceptive options in order from MOST appropriate to LEAST appropriate for this specific patient, taking into consideration her clinical presentation, body habitus, and time elapsed.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from most to least appropriate is: Oral ulipristal acetate, followed by Oral levonorgestrel, then Combined oral contraceptives (Yuzpe method), and finally the Copper T380A intrauterine device.
Appropriate emergency contraception selection requires factoring in efficacy limits and medical safety. Oral ulipristal acetate is the most appropriate choice because it retains efficacy up to 120 hours, is effective at a BMI up to 35 kg/m², and carries no infectious contraindications. Oral levonorgestrel is second; while safe from an infectious standpoint, it is poorly effective given the 90-hour delay and a BMI of 33 kg/m². The Yuzpe method is third, as it is safe but provides the lowest efficacy and the highest side-effect burden. Finally, the Copper IUD is the least appropriate—despite being the most potent emergency contraceptive overall, inserting a foreign body through an actively infected cervix (indicated by mucopurulent discharge and pelvic pain) is an absolute medical contraindication.

Step-by-Step Solution

1
Evaluate for absolute contraindications based on the physical examination.
The patient has signs of active pelvic inflammatory disease (mucopurulent cervicitis, cervical motion tenderness).
Active pelvic infection is a WHO Medical Eligibility Criteria Category 4 (absolute contraindication) for any intrauterine device insertion. Thus, the Copper IUD becomes the least appropriate method.
2
Evaluate the impact of the time elapsed since unprotected intercourse.
90 hours have elapsed.
Levonorgestrel is ideally used within 72 hours; its efficacy plummets significantly afterward. Ulipristal acetate maintains its efficacy up to 120 hours.
3
Evaluate the impact of the patient's body habitus.
The patient has a BMI of 33 kg/m².
Levonorgestrel loses significant efficacy in women with a BMI > 26 kg/m². Ulipristal acetate maintains efficacy up to a BMI of 35 kg/m².
4
Determine the final hierarchical order of the remaining safe methods.
Ulipristal > Levonorgestrel > Yuzpe method.
Ulipristal is superior due to time and weight factors. Levonorgestrel is superior to the Yuzpe method, which is the least effective oral option and causes severe nausea.

Key Concept

Selection of emergency contraception requires synthesizing three critical variables: time elapsed since intercourse, patient body mass index, and WHO Medical Eligibility Criteria regarding active infections.
Estimated Time:1m 30s
Question 563Question →

A 54-year-old male architect is evaluated for a first episode of pervasive sadness, early morning awakening, and severe anhedonia. Over the subsequent 14 months, his clinical course is characterized by progressive treatment resistance, ultimately culminating in an inpatient psychiatric admission for life-threatening symptoms. According to evidence-based stepped-care guidelines for Major Depressive Disorder, arrange the following management steps in the most appropriate chronological order, corresponding to his clinical evolution from initial presentation to severe, refractory illness.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of stepped-care management is: 1) Screen for bipolar disorder and medical mimics, 2) Initiate SSRI monotherapy, 3) Switch to an SNRI due to non-response and side effects, 4) Augment with aripiprazole for partial response, and 5) Initiate ECT for the development of psychotic features and food refusal.
The management of Major Depressive Disorder follows a highly evidence-based stepped-care algorithm. First, all patients must be screened for bipolar disorder and medical mimics (e.g., hypothyroidism) before initiating treatment to avoid precipitating mania. Second, an SSRI is the appropriate first-line pharmacotherapy. Third, if a patient has a complete lack of response and experiences intolerable side effects, the correct algorithmic step is to switch to a different class of antidepressant (e.g., an SNRI). Fourth, if a subsequent trial yields a partial response and is well-tolerated, the algorithm shifts to augmentation (e.g., adding an atypical antipsychotic like aripiprazole or a mood stabilizer like lithium) to build upon the partial gains. Finally, if the patient clinically deteriorates and develops life-threatening features, such as psychosis, catatonia, or refusal to eat, all standard outpatient pharmacotherapy algorithms are superseded by the need for immediate Electroconvulsive Therapy (ECT).

Step-by-Step Solution

1
Establish diagnosis and safety parameters.
Screen for bipolar disorder and check TSH.
Rule out bipolar disorder and medical mimics to prevent antidepressant-induced mania before any pharmacotherapy is started.
2
Initiate primary pharmacotherapy.
Start SSRI monotherapy.
SSRIs are the first-line standard of care for an uncomplicated initial episode of unipolar major depressive disorder.
3
Manage primary treatment failure.
Switch to an SNRI.
A complete lack of response combined with poor tolerability dictates switching to a different antidepressant class rather than augmenting.
4
Manage partial therapeutic response.
Augment with aripiprazole.
Partial improvement with good tolerability dictates adding an augmenting agent (like a second-generation antipsychotic or lithium) rather than abandoning the current effective drug.
5
Manage life-threatening clinical deterioration.
Initiate Electroconvulsive Therapy (ECT).
The emergence of psychotic features and food refusal represents a psychiatric emergency requiring immediate, highly effective intervention, for which ECT is the gold standard.

Key Concept

Stepped-care pharmacotherapy algorithm for Major Depressive Disorder (MDD), specifically distinguishing indications for switching versus augmentation, and identifying absolute indications for ECT.
Question 564Question →

A 33-year-old woman comes to the office after noticing a firm, painless lump in her left breast 2 weeks ago. Physical examination reveals a 2.5-cm, hard, nonmobile mass in the upper outer quadrant of the left breast without overlying skin changes. There is no palpable axillary lymphadenopathy. Assuming the mass is highly suspicious for early-stage invasive breast carcinoma, arrange the following steps in the most appropriate chronological sequence for her standard diagnostic workup and management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with imaging (mammography and ultrasound), followed by core needle biopsy for tissue diagnosis. Next, the tissue undergoes receptor testing. Once fully characterized, the patient undergoes breast-conserving surgery, which is then followed by adjuvant radiation therapy.
The standard protocol for evaluating and treating a suspicious breast mass in a woman aged 30 or older follows a stepwise approach: initial non-invasive imaging (mammography and ultrasound) to characterize the lesion, followed by a minimally invasive core needle biopsy for histologic diagnosis. Once confirmed as cancer, the tissue undergoes receptor profiling to guide overall therapy. Only after this comprehensive workup does the patient undergo definitive local surgical treatment, such as a lumpectomy with a sentinel lymph node biopsy. Because breast-conserving surgery leaves breast tissue behind, it must be followed by adjuvant whole-breast radiation therapy to minimize the risk of local recurrence.

Step-by-Step Solution

1
Order bilateral diagnostic mammography and targeted ultrasound.
Characterization of the breast mass and assessment of the contralateral breast and axilla.
This is the required first step in women aged 30 and older with a palpable breast mass.
2
Perform an image-guided core needle biopsy of the lesion.
Obtain a tissue sample for histological diagnosis.
A definitive tissue diagnosis is required to confirm malignancy before any surgical intervention.
3
Send the biopsy specimen for immunohistochemical receptor testing.
Determination of estrogen receptor, progesterone receptor, and HER2 status.
Receptor status dictates the need for targeted neoadjuvant or adjuvant systemic therapies and provides prognostic information.
4
Perform breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy.
Removal of the primary tumor with negative margins and axillary staging.
This provides definitive local surgical control for early-stage, localized breast cancer.
5
Administer adjuvant whole-breast radiation therapy.
Treatment of the remaining breast tissue.
Radiation is mandatory after breast-conserving surgery to reduce the risk of local tumor recurrence.

Key Concept

The chronological sequence for evaluating and managing a suspicious breast mass in a woman aged 30 or older involves non-invasive imaging, minimally invasive tissue sampling, comprehensive pathological profiling, local surgical control, and finally adjuvant radiation.
Question 565Question →

A 32-year-old primigravid woman at 8 weeks gestation presents to the clinic after noticing a firm, painless lump in her right breast. Examination reveals a 4-cm, hard, immobile mass in the upper outer quadrant with clinically positive axillary lymphadenopathy. She strongly desires to continue the pregnancy and wants to pursue comprehensive treatment to maximize her survival. Assuming the diagnostic workup ultimately confirms invasive ductal carcinoma, arrange the following management steps in the strictly indicated chronological order for this specific patient, from initial evaluation through to postpartum care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Targeted ultrasound, 2) Core needle biopsy, 3) Mastectomy, 4) Chemotherapy, 5) Radiotherapy.
The sequence reflects the mandatory safety constraints of pregnancy. The workup begins with ultrasound (safest imaging) followed by core biopsy (required for diagnosis). Because the patient is only at 8 weeks gestation (first trimester), chemotherapy cannot be given yet. Therefore, surgery (which is safe under general anesthesia in all trimesters) must precede chemotherapy. Chemotherapy is then initiated once the second trimester is reached. Finally, radiation therapy is absolutely contraindicated at all stages of pregnancy and must be placed last, in the postpartum period.

Step-by-Step Solution

1
Determine the initial imaging modality.
Targeted ultrasound.
In pregnant women of any age, ultrasound is the preferred initial imaging test for palpable breast masses to eliminate fetal radiation risk.
2
Establish a tissue diagnosis.
Core needle biopsy.
Imaging alone is insufficient to diagnose malignancy; core biopsy under local anesthesia is safe and strictly required before definitive treatment.
3
Select the safest initial definitive therapy for a first-trimester patient.
Mastectomy with axillary staging.
At 8 weeks gestation, chemotherapy is highly teratogenic. Surgery is the only safe major therapeutic intervention in the first trimester. Mastectomy is often chosen because breast-conserving therapy would require radiation, which cannot be safely delivered or delayed for 7+ months.
4
Determine the timing of systemic therapy.
Anthracycline-based chemotherapy in the second trimester.
Chemotherapy can be safely administered during the second and third trimesters, making it the next logical step after the patient recovers from surgery and enters the second trimester.
5
Determine the timing of radiation therapy.
Adjuvant radiotherapy postpartum.
Therapeutic radiation poses severe risks of fetal anomalies and childhood cancer regardless of trimester; thus, it is universally delayed until after delivery.

Key Concept

The management of breast cancer during pregnancy requires strict adherence to trimester-based contraindications: ultrasound and biopsy are safe anytime, surgery is safe anytime (but is the mandatory first therapeutic step in the 1st trimester), chemotherapy is contraindicated in the 1st trimester but safe in the 2nd/3rd, and radiation is contraindicated until postpartum.
Question 566Question →

A primary care physician is evaluating a 74-year-old patient who presents with her son for a routine wellness visit. The son mentions that his mother has been repeatedly asking the same questions and occasionally getting lost in familiar neighborhoods over the past year. Arrange the following steps in the most appropriate chronological order for the standard clinical evaluation and management of this patient's suspected cognitive impairment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with obtaining a detailed history and medication review, followed by formal cognitive testing, then ruling out reversible causes with laboratory tests and neuroimaging, and finally establishing a diagnosis to guide therapy.
The standard diagnostic approach to a patient presenting with cognitive decline follows a stepwise progression to ensure accurate diagnosis while minimizing unnecessary testing. The evaluation begins with a thorough clinical history and medication review to identify obvious reversible factors, such as polypharmacy. Next, an objective cognitive screening tool (like the MoCA or MMSE) must be administered to document the presence and severity of the cognitive deficit. Once cognitive impairment is established, the clinician orders laboratory tests (including TSH and Vitamin B12) and structural neuroimaging (such as a brain MRI) to exclude reversible systemic or structural etiologies (e.g., normal pressure hydrocephalus, vascular dementia, or tumors). Finally, after reversible causes have been ruled out and a specific neurocognitive disorder (e.g., Alzheimer disease) is diagnosed, a management plan involving symptomatic pharmacotherapy can be initiated.

Step-by-Step Solution

1
Obtain history and perform a medication review with collateral information.
Identifies the timeline of symptoms and potential iatrogenic contributors.
This is the fundamental first step in any patient evaluation to guide subsequent testing.
2
Administer an objective cognitive screen (e.g., MoCA or MMSE).
Quantifies the degree of cognitive impairment.
Objective evidence of cognitive decline is required before pursuing an expensive or invasive diagnostic workup.
3
Order laboratory tests (TSH, B12, CMP, CBC) and structural neuroimaging.
Rules out reversible causes of dementia.
Major neurocognitive disorder is largely a diagnosis of exclusion; reversible systemic or structural causes must be investigated.
4
Establish the diagnosis and initiate symptomatic treatment if appropriate.
Provides the patient and family with a management plan.
Therapies (such as cholinesterase inhibitors) can only be appropriately prescribed once the diagnosis is confirmed.

Key Concept

Diagnostic approach to neurocognitive disorders
Question 567Question →

A 35-year-old patient is diagnosed with severe Major Depressive Disorder without psychotic features. Arrange the following interventions in the standard sequential order of a stepped-care approach for this patient, progressing from the initial evaluation and management to interventions for highly treatment-resistant disease. Assume an inadequate clinical response to each preceding step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with screening for bipolar disorder and initiating first-line monotherapy, followed by optimizing or switching that monotherapy, then advancing to augmentation strategies, and finally utilizing electroconvulsive therapy for refractory cases.
The standard stepped-care algorithm for major depressive disorder begins with screening for bipolar disorder and starting a single first-line agent. If the response is inadequate, the dose is optimized or the patient is switched to another monotherapy. If monotherapy trials fail, an augmenting agent is added. Finally, if the patient is refractory to multiple pharmacological interventions, neuromodulation like ECT is utilized.

Step-by-Step Solution

1
Identify the standard initial evaluation and treatment for Major Depressive Disorder.
Screening for bipolar disorder followed by initiation of an SSRI or other first-line monotherapy.
SSRIs are preferred initial agents due to their safety and tolerability. Bipolar screening prevents antidepressant-induced mania.
2
Determine the next step when the initial medication trial is inadequate.
Optimizing the dose or switching to another monotherapy.
Before adding multiple medications, a single agent should be optimized to its maximal effective dose, or replaced if ineffective.
3
Establish the next pharmacological step for continued treatment resistance.
Augmentation with a second-generation antipsychotic or mood stabilizer.
Once monotherapy optimization fails, combining medications with different mechanisms (augmentation) is indicated.
4
Identify the definitive treatment for severe, refractory depression.
Electroconvulsive therapy (ECT).
ECT is the most effective treatment for depression but is typically reserved for treatment resistance due to logistical requirements and cognitive side effect considerations.

Key Concept

The stepped-care pharmacological management of major depressive disorder progresses sequentially from monotherapy to augmentation, and ultimately to neuromodulation for severe treatment resistance.
Question 568Question →

A 28-year-old woman is diagnosed with major depressive disorder and prescribed an oral selective serotonin reuptake inhibitor (SSRI). Arrange the following clinical events and milestones in the typical chronological order in which they are expected to occur during her treatment course, from the initial days of therapy to long-term management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate side effects, followed by neurovegetative symptom improvement, a period of heightened suicide risk, delayed mood improvement, and finally the continuation phase.
The established clinical timeline for SSRI treatment involves immediate onset of side effects (days 1-7), followed by early improvement in neurovegetative symptoms like energy and sleep (weeks 1-2). Because energy returns before mood improves, patients experience a critical window of increased suicide risk during this mismatch. Finally, core mood symptoms and anhedonia remit (weeks 4-6), allowing the patient to enter the continuation phase of treatment (months 2-8).

Step-by-Step Solution

1
Identify the immediate effects of starting an SSRI.
Gastrointestinal upset and agitation occur within days.
Serotonergic side effects precede therapeutic benefits due to immediate receptor activation.
2
Determine the first depressive symptoms to improve.
Neurovegetative symptoms (sleep, energy, appetite) improve within 1 to 2 weeks.
Physical and vegetative symptoms respond faster than core psychological symptoms.
3
Assess the clinical consequence of mismatched symptom improvement.
A period of elevated suicide risk occurs.
Patients gain the energy to act on suicidal ideation before their subjective mood and hopelessness improve.
4
Identify the timeline for core symptom resolution.
Mood and anhedonia improve after 4 to 6 weeks.
Receptor downregulation and downstream neurogenesis require several weeks to produce emotional recovery.
5
Determine the next phase of treatment after achieving remission.
The continuation phase begins.
Clinical guidelines recommend 4 to 9 months of continued treatment post-remission to prevent relapse.

Key Concept

Timeline of clinical response and side effects for antidepressant pharmacotherapy
Question 569Question →

A 42-year-old male marketing executive presents to the clinic for a two-month history of pervasive anhedonia, early morning awakening, and an unintentional 5-kg (11-lb) weight loss. He reports that his symptoms have severely impaired his concentration, leading to a recent formal reprimand at work. He is seeking pharmacologic treatment. Assuming this patient will eventually develop treatment-resistant depression over the next year, arrange the following clinical management steps in the standard chronological sequence according to evidence-based stepped-care guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing this patient's evolving treatment-resistant depression is: screening for bipolar disorder, titrating the initial SSRI to a maximum dose, augmenting with a second agent for partial response, switching to a different class upon augmentation failure, and finally utilizing ECT for severe treatment-resistant symptoms.
The standard stepped-care escalation for major depressive disorder begins with ruling out bipolar disorder to prevent antidepressant-induced mania. Once unipolar depression is confirmed, a first-line agent (e.g., an SSRI) is initiated and titrated to its maximum tolerated dose to ensure an adequate trial. If the patient has a partial response, augmenting with a second agent (like an atypical antipsychotic) is preferred to build on existing progress. If the augmented regimen fails, cross-tapering to a medication in a different class (e.g., an SNRI) is indicated. Finally, if the patient fails multiple adequate trials and develops severe, life-threatening symptoms such as active suicidality, electroconvulsive therapy (ECT) is the definitive next step for treatment-resistant depression.

Step-by-Step Solution

1
Prior to initiating any pharmacotherapy, comprehensively evaluate for bipolar disorder.
A detailed psychiatric history is obtained to rule out past manic or hypomanic episodes.
Antidepressant monotherapy in unrecognized bipolar disorder can induce a manic switch or rapid cycling.
2
Initiate a first-line antidepressant and optimize the dose.
Sertraline is started and titrated to the maximum tolerated therapeutic level over several weeks.
Subtherapeutic dosing is a leading cause of pseudo-resistance; an adequate trial requires maximizing the dose before changing strategies.
3
Implement an augmentation strategy for a partial therapeutic response.
A second-generation antipsychotic (e.g., aripiprazole) is added to the optimized sertraline regimen.
Augmentation is preferred over switching when a patient has a partial response, as it builds upon the partial efficacy already achieved without losing progress.
4
Switch to a different pharmacologic class if the augmented regimen fails.
The patient is cross-tapered from the SSRI to an SNRI (e.g., venlafaxine).
When an optimized and augmented trial fails, switching to an agent with a different mechanism of action (e.g., adding norepinephrine reuptake inhibition) is indicated.
5
Recommend neuromodulation for severe treatment-resistant depression.
Electroconvulsive therapy (ECT) is initiated.
After failing multiple adequate trials of different antidepressant classes, or with the emergence of life-threatening symptoms like severe suicidality, ECT becomes the treatment of choice.

Key Concept

The stepped-care escalation algorithm for major depressive disorder.
Question 570Question →

A 52-year-old woman undergoes a routine screening mammogram, which reveals a new 1.5-cm spiculated density in the upper outer quadrant of the right breast. She is completely asymptomatic and her past medical history is unremarkable. Arrange the following subsequent steps in her evaluation and management in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first perform diagnostic imaging, followed by a core needle biopsy, then placement of a radiopaque clip, and finally surgical excision.
The correct chronological sequence for evaluating a suspicious finding on a screening mammogram begins with complete diagnostic imaging. A screening mammogram provides limited views; therefore, diagnostic mammography (e.g., spot compression or magnification views) and targeted breast ultrasound are required to fully characterize the lesion and evaluate the axillary lymph nodes. Once the lesion's suspicious nature is confirmed radiologically, an image-guided core needle biopsy is performed to obtain a definitive tissue diagnosis. Immediately following the biopsy, a radiopaque marker clip is deployed into the biopsy bed. This crucial step ensures the exact site can be localized for future surgical excision, which is especially important if the tumor responds completely to neoadjuvant therapy or if the lesion is non-palpable. Finally, armed with the histologic diagnosis and a marked tumor site, the patient is referred for definitive surgical excision and axillary staging.

Step-by-Step Solution

1
Perform diagnostic mammography and targeted breast ultrasound
Characterization of the lesion (e.g., BI-RADS 4 or 5) and assessment for multifocal or contralateral disease
Screening mammograms only provide limited standard views. Comprehensive diagnostic imaging is required to fully evaluate the morphology of the mass and the axillary lymph nodes before any invasive procedure.
2
Perform an image-guided core needle biopsy
Procurement of tissue for histologic diagnosis
Tissue sampling is the standard of care for suspicious breast lesions to establish a definitive diagnosis, determine receptor status, and guide multidisciplinary treatment planning.
3
Deploy a radiopaque marker clip into the biopsy bed
Localization of the tumor site
A metallic clip marks the exact location of the biopsied mass. This ensures the site can be found during surgery even if the mass becomes non-palpable or completely resolves radiographically following neoadjuvant chemotherapy.
4
Refer for definitive surgical excision and axillary staging
Tumor resection and pathologic staging
Definitive surgical management (such as lumpectomy with sentinel lymph node biopsy) is performed after the diagnosis is confirmed and the site is securely marked.

Key Concept

The standard diagnostic workflow for an abnormal screening mammogram involves comprehensive diagnostic imaging, followed by core needle biopsy, radiopaque clip placement to mark the tumor bed, and subsequent definitive surgery.
Estimated Time:1m 0s
Question 571Question →

A 49-year-old woman is evaluated in the surgical oncology clinic due to rapid changes in her right breast over the past five weeks. She was initially treated at an urgent care clinic with a two-week course of oral clindamycin for presumed cellulitis, but the condition has progressively worsened. She has no personal or family history of breast malignancy and previously had normal screening mammograms. Vital signs are normal. Examination of the right breast reveals diffuse enlargement, marked erythema, and increased warmth. The skin demonstrates prominent pitting edema encompassing most of the breast surface. Palpation reveals diffuse, firm tissue thickening without a discrete localized lump. Hard, enlarged lymph nodes are palpable in the right axillary region.

Arrange the following clinical interventions in the most appropriate chronological order for the diagnosis, staging, and definitive management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of interventions is: 1) Bilateral diagnostic mammography and targeted ultrasonography, 2) Image-guided core needle biopsy of the breast and skin punch biopsy, 3) Systemic staging with cross-sectional imaging and bone scintigraphy, 4) Induction of systemic neoadjuvant chemotherapy, and finally 5) Modified radical mastectomy and axillary lymph node dissection.
The diagnosis and management of inflammatory breast cancer (IBC) require a multidisciplinary approach executed in a specific sequence. When a patient presents with classic signs of IBC (erythema, edema, peau d'orange) that do not respond to antibiotics, the first step is diagnostic imaging (mammography and ultrasound) to evaluate the breast and axilla. This is immediately followed by tissue diagnosis via core needle biopsy of the breast parenchyma and a punch biopsy of the affected skin to confirm dermal lymphatic invasion. Because IBC is inherently a locally advanced disease (Stage IIIB or IIIC) with a high propensity for early metastasis, complete systemic staging (e.g., CT chest/abdomen/pelvis and bone scan) must be performed next. Once distant metastasis is ruled out, the patient must receive systemic neoadjuvant chemotherapy as the initial treatment modality. Upfront surgery is strictly contraindicated due to the high likelihood of positive surgical margins and the need to promptly address micrometastatic spread. Following a clinical response to neoadjuvant chemotherapy, the patient undergoes a modified radical mastectomy (breast-conserving surgery is contraindicated in IBC), typically followed by postmastectomy radiation therapy.

Step-by-Step Solution

1
Recognize the clinical presentation as highly suspicious for Inflammatory Breast Cancer (IBC).
Identify the need for an urgent oncologic workup rather than further antibiotic therapy.
The patient has progressive breast erythema, edema, and peau d'orange that did not respond to antibiotics, which are classic signs of IBC.
2
Order bilateral diagnostic mammography and targeted ultrasonography.
Evaluate the extent of the local disease and identify regional lymph node involvement.
Imaging is the necessary first step to characterize the breast tissue, assess for underlying masses or calcifications, and guide subsequent biopsy targets.
3
Perform image-guided core needle biopsy of the breast and skin punch biopsy.
Obtain histologic confirmation of invasive carcinoma and dermal lymphatic tumor emboli.
A definitive tissue diagnosis is required before any oncologic therapy can be initiated. A skin punch biopsy specifically evaluates for dermal lymphatic invasion characteristic of IBC.
4
Order systemic staging (CT of the chest, abdomen, pelvis, and bone scan, or PET/CT).
Determine the presence or absence of distant metastatic disease.
IBC is categorized as locally advanced (Stage III) at a minimum and carries a high risk of occult distant metastasis at presentation. Staging must precede treatment because Stage IV disease significantly alters the management goals.
5
Administer neoadjuvant chemotherapy.
Reduce the local tumor burden, clear skin involvement, and treat potential micrometastatic disease.
Upfront systemic therapy is the standard of care for non-metastatic IBC to improve surgical outcomes and overall survival.
6
Perform modified radical mastectomy with axillary lymph node dissection.
Achieve definitive local surgical control.
Breast-conserving therapy (lumpectomy) is contraindicated in IBC due to the diffuse nature of the disease and unacceptably high recurrence rates. Mastectomy follows chemotherapy.

Key Concept

The diagnostic and management pathway for Inflammatory Breast Cancer follows a strict sequence: Imaging -> Biopsy -> Systemic Staging -> Neoadjuvant Chemotherapy -> Mastectomy -> Postmastectomy Radiation.
Question 572Question →

A 28-year-old woman presents to the outpatient clinic 3 months postpartum reporting an overwhelmingly sad mood, profound hypersomnia, hyperphagia, and a sensation of extreme heaviness in her arms and legs. She reports significant functional impairment, noting difficulty getting out of bed to care for her infant. To avoid common clinical pitfalls and ensure standard-of-care management, arrange the following steps in the correct chronological sequence, from the immediate diagnostic evaluation to the management of potential treatment refractoriness.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with screening for bipolarity, followed by ruling out medical/substance etiologies, initiating SSRI monotherapy, allowing 6 to 8 weeks for an adequate trial, and finally utilizing augmentation strategies if only a partial response is achieved.
The standard of care for a new depressive presentation dictates diagnostic safety first (ruling out bipolarity and medical causes), followed by evidence-based initiation of therapy (SSRI), adherence to pharmacodynamic timelines (6-8 week trial), and finally algorithmic escalation (augmentation) for persistent or partially treated symptoms.

Step-by-Step Solution

1
Rule out bipolar disorder.
Screen for history of mania/hypomania.
Patients with atypical depression features have a high rate of bipolar disorder; giving SSRI monotherapy to a bipolar patient can trigger a manic episode.
2
Rule out organic pathology.
Obtain labs and toxicology.
Conditions like postpartum thyroiditis or substance use must be excluded to confirm primary unipolar major depressive disorder.
3
Initiate primary treatment.
Prescribe an SSRI.
SSRIs are first-line for major depressive disorder, including cases with atypical or peripartum onset features.
4
Prevent premature discontinuation.
Wait 6 to 8 weeks at a therapeutic dose.
Neurobiological adaptations (e.g., receptor downregulation) take weeks; assessing efficacy too early leads to inappropriate medication changes.
5
Address treatment resistance.
Augment with an atypical antipsychotic or lithium.
If an adequate 6-8 week trial yields only a partial response, augmentation is the evidence-based next step in the stepped-care algorithm.

Key Concept

Algorithmic evaluation and stepped-care management of Major Depressive Disorder
Question 573Question →

An emergency medical team brings a 20-year-old female university student to the hospital after she fainted during a lecture. Her friends report she has been severely restricting her food intake and exercising excessively for the past 8 months. On arrival, she is lethargic but arousable. Her body mass index is calculated at 13.0 kg/m213.0\text{ kg/m}^2. Vital signs indicate profound bradycardia (38 /min38\text{ /min}) and hypotension (78/48 mm Hg78/48\text{ mm Hg}). Arrange the following interventions in the most appropriate chronological sequence for managing this patient's condition, progressing from immediate acute care to definitive long-term therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain an ECG and metabolic panel, followed by inpatient medical admission for caloric repletion, then initiation of cognitive-behavioral therapy, and finally transitioning to outpatient multidisciplinary care.
The management of severe anorexia nervosa follows a strict hierarchy of clinical needs. Immediate survival requires identifying acute cardiopulmonary and metabolic crises (via ECG and metabolic panel). Once the initial emergency assessment is complete, the patient must be admitted to an inpatient medical unit for cautious nutritional rehabilitation and continuous monitoring to prevent refeeding syndrome. Only after basic medical stability and some cognitive restoration are achieved can the patient effectively participate in core psychiatric treatments like cognitive-behavioral therapy. Finally, long-term maintenance is managed in an outpatient multidisciplinary setting to sustain recovery.

Step-by-Step Solution

1
Identify the immediate life-threatening risks associated with severe malnutrition, bradycardia, and hypotension.
Prioritize acute medical assessment with an ECG and laboratory evaluation.
Patients with severe anorexia nervosa are at high risk for fatal cardiac arrhythmias and severe electrolyte derangements which must be identified immediately.
2
Determine the appropriate setting for initial treatment after acute assessment.
Admit the patient to an inpatient medical unit for controlled refeeding and telemetry.
Hemodynamic instability and very low BMI necessitate medical admission to monitor for and prevent refeeding syndrome during initial caloric replenishment.
3
Determine the optimal timing for core psychological interventions.
Initiate cognitive-behavioral therapy (CBT) after medical stability is achieved.
Severely malnourished patients often lack the cognitive capacity to engage in intensive psychotherapy until basic nutritional rehabilitation has commenced.
4
Plan for longitudinal care and relapse prevention.
Transition the patient to an outpatient multidisciplinary eating disorder program.
Eating disorders are chronic conditions requiring long-term psychiatric, nutritional, and medical follow-up to maintain recovery.

Key Concept

The management of severe anorexia nervosa prioritizes immediate assessment of life-threatening cardiac and metabolic complications, followed by inpatient medical stabilization to prevent refeeding syndrome, before advancing to definitive psychotherapy and long-term outpatient care.
Question 574Question →

A 72-year-old woman is brought to the clinic by her daughter due to a 1-year history of progressive memory loss, misplacing items, and getting lost in familiar neighborhoods. Arrange the following steps in the most appropriate chronological order for the initial diagnostic evaluation of this patient's progressive cognitive decline.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The diagnostic workup for cognitive decline sequentially involves: history and physical examination, objective cognitive screening, laboratory testing for reversible causes, and finally structural neuroimaging.
The standard approach to evaluating a patient with progressive cognitive decline follows a stepwise sequence. It begins with a comprehensive history and physical exam (including collateral history) to define the clinical syndrome. Next, an objective cognitive screening tool (e.g., MoCA, MMSE) is administered to quantify the impairment. Once impairment is confirmed, laboratory tests (TSH, Vitamin B12, CMP, CBC) are drawn to rule out reversible metabolic causes. Finally, structural neuroimaging (non-contrast CT or MRI) is obtained to rule out structural lesions (such as subdural hematoma, tumors, or normal pressure hydrocephalus) and support specific neurodegenerative diagnoses.

Step-by-Step Solution

1
Identify the patient's presentation as suspected major neurocognitive disorder (dementia).
The patient has a 1-year history of progressive functional impairment and memory loss.
Recognizing the broad clinical syndrome guides the standard algorithmic workup.
2
Place the history and physical examination as the first action.
History and physical is ranked first.
Patient assessment universally begins with direct clinical evaluation and collateral information gathering.
3
Determine the next step to confirm the suspected diagnosis.
Objective cognitive screening is ranked second.
Subjective complaints must be verified and quantified using standardized tools like the MMSE or MoCA.
4
Sequence the diagnostic tests to rule out secondary causes.
Laboratory testing is ranked third, followed by neuroimaging as the final step in this initial workup list.
Blood work is a minimally invasive way to rapidly identify reversible metabolic causes (e.g., hypothyroidism), while structural neuroimaging completes the standard diagnostic criteria for major neurocognitive disorders by ruling out space-occupying lesions or vascular disease.

Key Concept

The standard diagnostic sequence for evaluating progressive cognitive decline.
Question 575Question →

A 28-year-old woman presents to the outpatient clinic seeking treatment for heroin addiction. She states that her last heroin use was approximately 18 hours ago. She currently complains of severe muscle aches, abdominal cramps, and anxiety. On physical examination, she exhibits rhinorrhea, piloerection, and pupillary dilation. The physician plans to initiate treatment with buprenorphine-naloxone. Arrange the following steps in the most appropriate sequential order for the comprehensive management of this patient's opioid use disorder, from immediate acute presentation to long-term care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Assessment of withdrawal severity, followed by Induction with buprenorphine-naloxone, followed by Titration to an effective maintenance dose, and finally Integration of long-term psychosocial support.
The appropriate management of opioid use disorder begins with an objective assessment of withdrawal severity (e.g., using the Clinical Opiate Withdrawal Scale). Because buprenorphine is a partial mu-opioid agonist with high affinity, administering it too early can precipitate severe withdrawal. Once moderate withdrawal is confirmed, induction with buprenorphine-naloxone is performed. Over the next few days, the dose is titrated to a steady maintenance level that suppresses cravings. Finally, for the highest chance of sustained remission, pharmacological maintenance is combined with long-term behavioral counseling.

Step-by-Step Solution

1
Quantify the severity of acute opioid withdrawal.
Objective confirmation that the patient is in moderate to severe withdrawal.
Buprenorphine is a partial mu-opioid agonist. Administering it while full agonists are still occupying receptors can precipitate severe withdrawal.
2
Induce with buprenorphine-naloxone.
Relief of acute withdrawal symptoms.
Once appropriate withdrawal severity is confirmed, the initial dose safely displaces any remaining full agonists and begins treating the withdrawal syndrome.
3
Titrate the medication to a maintenance dose.
Achieve a stable maintenance dose that prevents relapse.
The dose must be carefully adjusted over subsequent days to ensure cravings are completely suppressed.
4
Provide long-term psychosocial support.
Long-term relapse prevention and behavioral modification.
Pharmacotherapy combined with behavioral counseling yields the highest rates of sustained recovery in opioid use disorder.

Key Concept

The clinical sequence for Opioid Use Disorder management using buprenorphine requires assessing for moderate withdrawal prior to induction to avoid precipitated withdrawal, followed by dose stabilization and long-term counseling.
Question 576Question →

A 42-year-old accountant is evaluated for a two-month history of pervasive sad mood, anhedonia, and poor concentration. He is seeking treatment for the first time. Arrange the following clinical steps in the standard chronological order they should be considered, starting with the initial evaluation and progressing through the escalation of care for increasingly treatment-resistant depression.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Screen for a prior history of manic or hypomanic episodes, 2) Initiate monotherapy with a selective serotonin reuptake inhibitor, 3) Augment the regimen with a second-generation antipsychotic, 4) Refer for electroconvulsive therapy.
The standard approach to a new depressive episode requires first ruling out bipolar disorder by screening for past mania or hypomania. Once unipolar depression is established, a selective serotonin reuptake inhibitor is the preferred first-line treatment. If the patient has a partial response despite an adequate trial and dose optimization, augmentation with an agent like a second-generation antipsychotic is indicated. Electroconvulsive therapy is generally reserved for severe, highly treatment-resistant depression that has not responded to multiple pharmacological interventions.

Step-by-Step Solution

1
Perform initial safety and diagnostic screening
Screen for a prior history of manic or hypomanic episodes
Administering an antidepressant without ruling out bipolar disorder can precipitate mania.
2
Select first-line therapy for unipolar depression
Initiate monotherapy with a selective serotonin reuptake inhibitor
SSRIs have a favorable side effect profile and are the standard initial treatment for major depressive disorder.
3
Manage partial response to monotherapy
Augment the regimen with a second-generation antipsychotic
When dose optimization of an initial agent yields incomplete remission, adding an augmenting agent is appropriate.
4
Address severe, refractory depression
Refer for electroconvulsive therapy
ECT is highly efficacious and is utilized after multiple medication trials fail.

Key Concept

The stepped-care management of major depressive disorder begins with ruling out bipolar disorder, followed by initial SSRI monotherapy, subsequent augmentation for partial responders, and eventually ECT for severe, refractory cases.
Question 577Question →

A 42-year-old executive is diagnosed with severe Major Depressive Disorder (MDD) without psychotic features. Despite excellent medication adherence, the patient's symptoms prove progressively difficult to treat over several months. Arrange the following steps in the standard evidence-based sequence for the management and escalation of care for MDD, from initial presentation through to the management of severe treatment-resistant depression.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with initiating a first-line monotherapy, followed by optimizing its dose and duration. If there is no response, switching to another monotherapy is indicated. If the new agent yields only a partial response, augmentation is utilized. Finally, ECT is reserved for refractory, treatment-resistant cases.
The pharmacological management of MDD follows a stepped-care approach to balance efficacy and tolerability. Treatment begins with an initial monotherapy (e.g., an SSRI) which must be optimized in dose and duration (4 to 8 weeks) before definitively assessing response. If there is a complete lack of response, switching to another first-line agent is preferred. If a subsequent trial yields a partial response, augmentation is indicated to push the patient toward full remission. Neuromodulation, such as ECT, is utilized for severe, treatment-resistant depression when multiple trials of optimized and augmented pharmacotherapy fail.

Step-by-Step Solution

1
Identify the standard first-line treatment for uncomplicated MDD.
Initiation of a first-line agent such as an SSRI.
First-line agents are preferred due to their favorable side-effect profiles and safety.
2
Determine the requirements for an adequate medication trial.
Titration to the maximum tolerated dose for 4-8 weeks.
Antidepressants require time to exert their full clinical effect; premature discontinuation leads to false treatment resistance.
3
Select the appropriate strategy for initial non-response.
Switch to a different monotherapy.
When a patient shows minimal or no response to an initial optimized trial, switching agents is generally preferred over augmentation.
4
Select the appropriate strategy for a subsequent partial response.
Augmentation with an atypical antipsychotic or lithium.
If a patient has a partial response, adding an adjunctive agent can push the patient toward full remission without losing the partial gains achieved.
5
Identify the treatment of last resort for non-psychotic, treatment-resistant depression.
Electroconvulsive therapy (ECT).
ECT is indicated when multiple trials of pharmacotherapy, including augmentation strategies, have failed.

Key Concept

Stepped-care management and escalation algorithm for Major Depressive Disorder
Question 578Question →

A 54-year-old postmenopausal woman visits her physician after discovering a firm lump in her right breast. Clinical examination confirms a 2.5-cm, non-tender, relatively fixed mass in the right upper outer quadrant without palpable axillary lymphadenopathy. There is no overlying skin dimpling or nipple retraction. Arrange the following clinical steps in the most appropriate chronological sequence for the standard evaluation and definitive management of this patient's newly discovered breast mass.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for evaluating and managing a palpable breast mass in a woman aged 30 or older begins with diagnostic imaging, followed by a core needle biopsy, molecular characterization of the tumor, primary surgical intervention, and finally adjuvant therapies.
The standard sequence for a new palpable breast mass in a patient older than 30 begins with bilateral diagnostic mammography to evaluate the mass and screen the remainder of the breast tissue. This is followed by an image-guided core needle biopsy for a definitive histologic diagnosis. Once malignancy is confirmed, receptor testing (ER/PR/HER2) is performed on the biopsy specimen to guide treatment. The patient then undergoes definitive surgical management (e.g., lumpectomy with sentinel lymph node biopsy). Finally, adjuvant therapies (radiation, endocrine therapy, chemotherapy) are administered based on the final surgical pathology and receptor status.

Step-by-Step Solution

1
Perform initial diagnostic imaging.
Characterizes the palpable mass and evaluates the rest of the breast tissue.
Women aged 30 and older with a breast mass require diagnostic mammography and ultrasound before any invasive procedures.
2
Perform core needle biopsy.
Provides a histologic tissue sample.
Solid, suspicious masses require tissue diagnosis to confirm malignancy and differentiate from benign pathology.
3
Test biopsy tissue for hormone and HER2 receptors.
Determines the tumor's molecular subtype.
Receptor status is critical for planning the appropriate multidisciplinary management.
4
Perform surgical resection.
Removes the primary tumor and stages the axilla.
Definitive local control is achieved through surgical excision (lumpectomy or mastectomy) with lymph node evaluation.
5
Administer adjuvant therapy.
Reduces the risk of local and distant recurrence.
Systemic and local adjuvant treatments follow surgery based on tumor characteristics and surgical pathology.

Key Concept

Diagnostic and management sequence for a palpable breast mass in women aged 30 and older.
Question 579Question →

An otherwise healthy 42-year-old patient is evaluated in the outpatient setting for a new-onset, continuous, clear vaginal leakage. Two weeks prior, she underwent a complicated total laparoscopic hysterectomy for severe endometriosis involving dense pelvic adhesions. Her vital signs are within normal limits. A pelvic examination reveals clear fluid pooling in the vaginal vault, while the vaginal cuff appears intact and is healing appropriately. The physician suspects a postoperative urinary tract fistula. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the retrograde instillation of bladder dye, followed by vaginal inspection to rule out a vesicovaginal fistula, intravenous dye administration to confirm a ureterovaginal fistula, CT urography for anatomic localization, and finally, ureteral stenting for therapeutic management.
The correct sequence follows the standard diagnostic and therapeutic algorithm for a suspected post-hysterectomy urinary fistula. The initial step is to clinically differentiate the source of the fluid. Because vesicovaginal fistulas (VVFs) are the most common, a retrograde dye test (e.g., methylene blue via Foley catheter) is performed first. Inspection of the vagina then verifies if the bladder is intact. If no dye leaks, a VVF is ruled out. Next, intravenous dye (e.g., indigo carmine) is administered; it is filtered by the kidneys and travels down the ureters. If this dye appears in the vagina, a ureterovaginal fistula (UVF) is confirmed. Once clinically diagnosed, cross-sectional imaging (CT urography) is required to delineate the precise location, severity, and any associated complications (like a urinoma). Finally, initial management involves urinary diversion, typically achieved via cystoscopy and retrograde ureteral stenting, which allows the tissue to heal conservatively and reduces inflammation before any delayed surgical intervention is considered.

Step-by-Step Solution

1
Test for vesicovaginal fistula (VVF) by instilling methylene blue into the bladder.
The bladder is filled with dye, allowing for evaluation of lower urinary tract integrity.
VVF is the most common post-hysterectomy fistula and must be ruled out first.
2
Inspect the vagina for blue dye.
No blue dye is observed in the vagina.
This negative result clinically rules out a VVF, indicating the leak is higher in the urinary tract.
3
Administer IV indigo carmine or oral phenazopyridine.
Dye appears in the vaginal vault.
The dye is excreted via the kidneys into the ureters. Its presence in the vagina confirms a ureterovaginal fistula (UVF).
4
Perform CT urography.
The exact location and severity of the ureteral thermal injury or transection is identified.
Imaging is necessary for surgical planning and to evaluate for associated urinomas or hydronephrosis.
5
Place a retrograde ureteral stent.
Urine is diverted away from the fistula tract.
Stenting promotes conservative healing. If unsuccessful, definitive surgical reimplantation (ureteroneocystostomy) is delayed for 6-12 weeks to allow inflammation to subside.

Key Concept

The step-wise clinical diagnosis of a postoperative genitourinary fistula involves ruling out a vesicovaginal fistula using retrograde bladder dye before confirming a ureterovaginal fistula with intravenous dye, followed by imaging and ureteral stenting.
Estimated Time:2m 0s
Question 580Question →

A psychiatric evaluation requires careful assessment of symptom duration to differentiate between primary psychotic disorders. Arrange the following diagnoses in correct chronological order based on the minimum continuous duration of symptoms required to meet diagnostic criteria, starting with the shortest duration and ending with the longest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence based on symptom duration is: Brief psychotic disorder (1 day to less than 1 month), followed by Schizophreniform disorder (1 month to less than 6 months), and finally Schizophrenia (6 months or greater).
The diagnostic classification of primary psychotic spectrum disorders relies heavily on the total duration of the symptoms. Brief psychotic disorder is characterized by a rapid onset of psychotic symptoms that last at least 1 day but fully resolve within 1 month. If symptoms persist for at least 1 month but less than 6 months, the correct diagnosis is schizophreniform disorder. Once continuous signs of the disturbance (including the active phase, prodromal, or residual symptoms) have been present for at least 6 months, the diagnosis is classified as schizophrenia.

Step-by-Step Solution

1
Identify the time criterion for Brief psychotic disorder.
Symptoms must last from 1 day to less than 1 month.
By definition, a brief psychotic episode is acute and self-limiting within a one-month timeframe.
2
Identify the time criterion for Schizophreniform disorder.
Symptoms must last from 1 month to less than 6 months.
Schizophreniform disorder occupies the intermediate duration between a brief psychotic episode and full schizophrenia.
3
Identify the time criterion for Schizophrenia.
Symptoms must last for at least 6 months.
A diagnosis of schizophrenia requires a minimum of 6 months of continuous disturbance, which may include prodromal or residual periods.

Key Concept

Diagnostic timeline for primary psychotic disorders
Estimated Time:45s
PreviousPage 29 / 85Next